CLINICAL_TRIALS
trial_result
· 2011-06-07
Clinical Trial Update: Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases [Phase 2]
Summary
Phase 2 trial of tandutinib in progressive prostate cancer with bone metastases completed; results were posted in June 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Cancer, Pain | Phase 2 | Status: COMPLETED | Results posted: 2011-06-07